Literature DB >> 25339765

Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.

Yosuke Maeda1, Hiromi Terasawa2, Yuetsu Tanaka3, Chisho Mitsuura2, Kaori Nakashima2, Keisuke Yusa4, Shinji Harada2.   

Abstract

UNLABELLED: Interaction of the envelope glycoprotein (Env) of human T-lymphotropic virus 1 (HTLV-1) with the glucose transporter type 1 (GLUT1) expressed in target cells is essential for viral entry. This study found that the expression level of GLUT1 in virus-producing 293T cells was inversely correlated with HTLV-1 Env-mediated fusion activity and infectivity. Chimeric studies between GLUT1 and GLUT3 indicated that the extracellular loop 6 (ECL6) of GLUT1 is important for the inhibition of cell-cell fusion mediated by Env. When GLUT1 was translocated into the plasma membrane from intracellular storage sites by bafilomycin A1 (BFLA1) treatment in 293T cells, HTLV-1 Env-mediated cell fusion and infection also were inhibited without the overexpression of GLUT1, indicating that the localization of GLUT1 in intracellular compartments rather than in the plasma membrane is crucial for the fusion activity of HTLV-1 Env. Immunoprecipitation and laser scanning confocal microscopic analyses indicated that under normal conditions, HTLV-1 Env and GLUT1 do not colocalize or interact. BFLA1 treatment induced this colocalization and interaction, indicating that GLUT1 normally accumulates in intracellular compartments separate from that of Env. Western blot analyses of FLAG-tagged HTLV-1 Env in virus-producing cells and the incorporation of HTLV-1 Env in virus-like particles (VLPs) indicate that the processing of Env is inhibited by either overexpression of GLUT1 or BFLA1 treatment in virus-producing 293T cells. This inhibition probably is due to the interaction of the Env with GLUT1 in intracellular compartments. Taken together, separate intracellular localizations of GLUT1 and HTLV-1 Env are required for the fusion activity and infectivity of HTLV-1 Env. IMPORTANCE: The deltaretrovirus HTLV-1 is a causative agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although HTLV-1 is a complex retrovirus that has accessory genes, no HTLV-1 gene product has yet been shown to regulate its receptor GLUT1 in virus-producing cells. In this study, we found that a large amount of GLUT1 or translocation of GLUT1 to the plasma membrane from intracellular compartments in virus-producing cells enhances the colocalization and interaction of GLUT1 with HTLV-1 Env, leading to the inhibition of cell fusion activity and infectivity. The results of our study suggest that GLUT1 normally accumulates in separate intracellular compartments from Env, which is indeed required for the proper processing of Env.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25339765      PMCID: PMC4301130          DOI: 10.1128/JVI.02686-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion.

Authors:  M Osame; R Janssen; H Kubota; H Nishitani; A Igata; S Nagataki; M Mori; I Goto; H Shimabukuro; R Khabbaz
Journal:  Ann Neurol       Date:  1990-07       Impact factor: 10.422

2.  Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37.

Authors:  L G Perez; E Hunter
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

4.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

5.  Homology of human T-cell leukaemia virus envelope gene with class I HLA gene.

Authors:  M F Clarke; E P Gelmann; M S Reitz
Journal:  Nature       Date:  1983 Sep 1-7       Impact factor: 49.962

6.  Isolation and transmission of human retrovirus (human t-cell leukemia virus).

Authors:  M Popovic; P S Sarin; M Robert-Gurroff; V S Kalyanaraman; D Mann; J Minowada; R C Gallo
Journal:  Science       Date:  1983-02-18       Impact factor: 47.728

7.  Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.

Authors:  J M McCune; L B Rabin; M B Feinberg; M Lieberman; J C Kosek; G R Reyes; I L Weissman
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

8.  In vivo cellular tropism of human T-cell leukemia virus type 1.

Authors:  J H Richardson; A J Edwards; J K Cruickshank; P Rudge; A G Dalgleish
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

9.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.

Authors:  Yorifumi Satou; Atae Utsunomiya; Junko Tanabe; Masanori Nakagawa; Kisato Nosaka; Masao Matsuoka
Journal:  Retrovirology       Date:  2012-05-30       Impact factor: 4.602

View more
  8 in total

1.  Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.

Authors:  Mako Toyoda; Yoko Ogata; Macdonald Mahiti; Yosuke Maeda; Xiaomei T Kuang; Toshiyuki Miura; Heiko Jessen; Bruce D Walker; Mark A Brockman; Zabrina L Brumme; Takamasa Ueno
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 2.  T cell metabolism in chronic viral infection.

Authors:  L J Pallett; N Schmidt; A Schurich
Journal:  Clin Exp Immunol       Date:  2019-05-20       Impact factor: 4.330

3.  HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.

Authors:  Keiko Yasuma; Toshio Matsuzaki; Yoshihisa Yamano; Hiroshi Takashima; Masao Matsuoka; Mineki Saito
Journal:  J Neurovirol       Date:  2015-12-03       Impact factor: 2.643

Review 4.  HTLV-1: A real pathogen or a runaway guest of a diseased cell?

Authors:  L I B Kanzaki
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

5.  HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1.

Authors:  Jacob Al-Saleem; Wessel P Dirksen; Michael P Martinez; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Lee Ratner; Patrick L Green
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

Review 6.  HTLV-1 infection of myeloid cells: from transmission to immune alterations.

Authors:  Brenda Rocamonde; Auriane Carcone; Renaud Mahieux; Hélène Dutartre
Journal:  Retrovirology       Date:  2019-12-23       Impact factor: 4.602

7.  Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.

Authors:  Jie Hu; Qingzhu Gao; Yang Yang; Jie Xia; Wanjun Zhang; Yao Chen; Zhi Zhou; Lei Chang; Yuan Hu; Hui Zhou; Li Liang; Xiaosong Li; Quanxin Long; Kai Wang; Ailong Huang; Ni Tang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 8.  Molecular Studies of HTLV-1 Replication: An Update.

Authors:  Jessica L Martin; José O Maldonado; Joachim D Mueller; Wei Zhang; Louis M Mansky
Journal:  Viruses       Date:  2016-01-27       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.